Female patients who intend to donate eggs (ova) during the course of this study or  months after receiving their last dose of study drug(s)
Female subject must agree not to breastfeed at screening and throughout the study period and for  days after the final study drug administration. Female subject must not donate ova starting at screening and throughout the study period and for  days after the final study drug administration.
Female participants must agree not to breastfeed or donate ova throughout the study drug treatment period and for  months after the final study drug administration.
If of reproductive potential, agrees to use a highly effective from of contraception or avoid intercourse during and upon completion of the study and for at least  months after the last dose of study drug, and agrees not to retrieve, freeze or donate sperm or ova starting at Screening and throughout the study period, and at least  months after the final study drug administration
Female patients who intend to donate eggs (ova) during the course of this study or  months after receiving their last dose of study drug(s)
Female subject who is of childbearing potential must agree not to breastfeed starting at screening and throughout the study and for  days after the final study drug administration.
Female subject who is of childbearing potential must not donate ova starting at screening and throughout the study and for  days after the final study drug administration.
Female subject must agree not to breastfeed starting at Screening and throughout the study period, and for  months after the final study drug administration.
Female subject must not donate ova starting at Screening and throughout the study period, and for  months after the final study drug administration.
Female patients who intend to donate eggs (ova) during the course of this study or  months after receiving their last dose of study drug(s)
Is not breastfeeding at screening and will not breastfeed throughout the study period and for at least  months after final drug administration
Female subject must agree not to breastfeed starting at Screening and throughout the study period, and for  months after the final study treatment administration.
Female subject must not donate ova starting at Screening and throughout the study period, and for  months after the final study drug administration.
Female patients who intend to donate eggs (ova) during the course of this study or  months after receiving their last dose of study drug(s)
Female patients who intend to donate eggs (ova) during the course of this study or  months after receiving their last dose of study drug(s)
Female subject must agree not to breastfeed at Screening and throughout the study period and for  days after the final study drug administration.
Female subject must not donate ova starting at Screening and throughout the study period and for  days after the final study drug administration.
Female Subjects must agree to not breastfeed from the time of Screening and throughout the study period, and for  days after the final study drug administration.
Female subject must agree not to breastfeed starting at Screening and throughout the study period, and for  days after the final study drug administration.
Female subject must not donate ova starting at Screening and throughout the study period, and for  days after the final study drug administration.
Female participants who intend to donate eggs (ova) during the course of this study or  months after receiving their last dose of study drug(s).
Female subject must agree not to breastfeed starting at screening and throughout the study period, and for  days after the final study drug administration.
Female subject must not donate ova starting at screening and throughout the study period, and for  days after the final study drug administration.
Female subject must not donate ova starting at Screening and throughout the study period, and for  days after the final study drug administration.
Female patients who intend to donate eggs (ova) during the course of this study or  months after receiving their last dose of study drug(s)
Female subject must not donate ova starting at Screening and throughout the study period, and for  days after the final study drug administration.
Female subject must agree not to breastfeed at screening and throughout the study period, and for  days after the final study drug administration.
Female subject must not donate ova starting at screening and throughout the study period, and for  days after the final study drug administration.
Female subject must not donate ova starting at screening and throughout the study period and for  days after final study drug administration.
Female subject must not donate ova starting at screening and throughout the study period, and for  days after the final study drug administration.
Female subject must agree not to breastfeed starting at screening and throughout the study period, and for  months and  week after the final study drug administration.
Female subject must not donate ova starting at screening and throughout the study period, and for  months after the final study drug administration.
